Procter & Gamble (NYSE:PG) Research Coverage Started at Piper Sandler

Research analysts at Piper Sandler initiated coverage on shares of Procter & Gamble (NYSE:PG) in a research report issued on Tuesday, Briefing.com reports. The brokerage set a “neutral” rating and a $174.00 price target on the stock. Piper Sandler’s price objective would suggest a potential upside of 0.13% from the stock’s current price.

A number of other research analysts have also recently issued reports on PG. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Citigroup upped their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Jefferies Financial Group downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price objective for the company from $182.00 to $175.00 in a research note on Wednesday, July 24th. BNP Paribas started coverage on shares of Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 target price on the stock. Finally, Barclays dropped their price target on Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a research note on Thursday, August 1st. Eight equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus price target of $175.89.

Procter & Gamble Stock Performance

NYSE PG opened at $173.77 on Tuesday. The firm’s 50 day simple moving average is $170.40 and its 200 day simple moving average is $165.88. The firm has a market capitalization of $410.12 billion, a price-to-earnings ratio of 28.39, a P/E/G ratio of 3.84 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. Procter & Gamble has a 1 year low of $141.45 and a 1 year high of $177.94.

Procter & Gamble (NYSE:PG) last issued its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. During the same quarter last year, the business posted $1.37 EPS. The company’s revenue was down .1% compared to the same quarter last year. As a group, research analysts expect that Procter & Gamble will post 6.97 earnings per share for the current fiscal year.

Insider Activity at Procter & Gamble

In other news, CEO Jon R. Moeller sold 72,174 shares of Procter & Gamble stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the transaction, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at approximately $45,002,649.58. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Jon R. Moeller sold 72,174 shares of Procter & Gamble stock in a transaction on Friday, August 9th. The shares were sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the completion of the sale, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at $45,002,649.58. The disclosure for this sale can be found here. Insiders have sold a total of 375,553 shares of company stock worth $63,829,141 over the last quarter. Company insiders own 0.17% of the company’s stock.

Institutional Trading of Procter & Gamble

Large investors have recently made changes to their positions in the company. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble during the 2nd quarter valued at $28,000. Fairway Wealth LLC acquired a new position in shares of Procter & Gamble during the second quarter valued at about $29,000. Transcendent Capital Group LLC bought a new stake in shares of Procter & Gamble during the fourth quarter worth about $31,000. Ruedi Wealth Management Inc. increased its position in shares of Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares in the last quarter. Finally, POM Investment Strategies LLC bought a new position in Procter & Gamble in the 2nd quarter valued at about $34,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.